We are studying whether adding Obinutuzumab to local radiotherapy improves outcomes for patients with early-stage Follicular Lymphoma. This trial will help us understand the effectiveness and safety of this combination treatment.
Health conditions and diseases that the clinical trial is designed to study and treat.
Early Stage Follicular Lymphoma is a type of cancer that affects the lymphatic system, specifically the B-cells, and is characterized by the slow growth of abnormal lymphocytes. It often presents with swollen lymph nodes and may not cause significant symptoms in its early stages.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.